Yao Ming Kangde said on an interactive platform on September 30 that AI is currently in the exploration and testing stage in the field of innovative drug development. In the future, it is expected to greatly improve efficiency, lower the threshold, and promote the rapid growth of innovators and innovative ideas. Although AI can efficiently design molecular structures, it still requires a unique integrated, end-to-end CRDMO platform like the company for complex synthesis delivery and biological verification, thus forming an inseparable industrial closed loop of “AI design+CXO enabling implementation”. To this end, the company always adheres to the “HI+AI” strategy and uses innovative tools to continuously improve service capabilities and operational efficiency to better serve customers around the world. In the future, excellent CXOs will evolve into “life science operating systems” connecting cutting-edge AI brains and physical R&D processes, amplifying their own value through continuous iteration and ultimately benefiting patients.

Yao Ming Kangde said on an interactive platform on September 30 that AI is currently in the exploration and testing stage in the field of innovative drug development. In the future, it is expected to greatly improve efficiency, lower the threshold, and promote the rapid growth of innovators and innovative ideas. Although AI can efficiently design molecular structures, it still requires a unique integrated, end-to-end CRDMO platform like the company for complex synthesis delivery and biological verification, thus forming an inseparable industrial closed loop of “AI design+CXO enabling implementation”. To this end, the company always adheres to the “HI+AI” strategy and uses innovative tools to continuously improve service capabilities and operational efficiency to better serve customers around the world. In the future, excellent CXOs will evolve into “life science operating systems” connecting cutting-edge AI brains and physical R&D processes, amplifying their own value through continuous iteration and ultimately benefiting patients.